Ovarian cancer lacks specific symptoms and current tests, such as serum Cancer Antigen 125 (CA125) and transvaginal ultrasound scans (TVS), lack reliability for early diagnosis and screening, leading to around two-thirds of women being diagnosed at an advanced stage (stages III and IV) [2]. Here, MUC16 is linked to ovarian carcinoma.